123 related articles for article (PubMed ID: 9889963)
1. Cytotoxic T lymphocytes in resistance to tuberculosis.
Mazzaccaro RJ; Stenger S; Rock KL; Porcelli SA; Brenner MB; Modlin RL; Bloom BR
Adv Exp Med Biol; 1998; 452():85-101. PubMed ID: 9889963
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.
Mazzaccaro RJ; Gedde M; Jensen ER; van Santen HM; Ploegh HL; Rock KL; Bloom BR
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11786-91. PubMed ID: 8876215
[TBL] [Abstract][Full Text] [Related]
3. Nonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against Infection.
Shang S; Siddiqui S; Bian Y; Zhao J; Wang CR
PLoS Pathog; 2016 Jun; 12(6):e1005688. PubMed ID: 27272249
[TBL] [Abstract][Full Text] [Related]
4. MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.
Bian Y; Shang S; Siddiqui S; Zhao J; Joosten SA; Ottenhoff THM; Cantor H; Wang CR
PLoS Pathog; 2017 May; 13(5):e1006384. PubMed ID: 28475642
[TBL] [Abstract][Full Text] [Related]
5. The human macrophage cell line U937 as an in vitro model for selective evaluation of mycobacterial antigen-specific cytotoxic T-cell function.
Passmore JS; Lukey PT; Ress SR
Immunology; 2001 Feb; 102(2):146-56. PubMed ID: 11260319
[TBL] [Abstract][Full Text] [Related]
6. Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis.
De La Barrera SS; Finiasz M; Frias A; Alemán M; Barrionuevo P; Fink S; Franco MC; Abbate E; del C Sasiain M
Clin Exp Immunol; 2003 Jun; 132(3):450-61. PubMed ID: 12780692
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.
Schaible UE; Winau F; Sieling PA; Fischer K; Collins HL; Hagens K; Modlin RL; Brinkmann V; Kaufmann SH
Nat Med; 2003 Aug; 9(8):1039-46. PubMed ID: 12872166
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.
Joosten SA; van Meijgaarden KE; van Weeren PC; Kazi F; Geluk A; Savage ND; Drijfhout JW; Flower DR; Hanekom WA; Klein MR; Ottenhoff TH
PLoS Pathog; 2010 Feb; 6(2):e1000782. PubMed ID: 20195504
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterial infection of macrophages results in membrane-permeable phagosomes.
Teitelbaum R; Cammer M; Maitland ML; Freitag NE; Condeelis J; Bloom BR
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15190-5. PubMed ID: 10611360
[TBL] [Abstract][Full Text] [Related]
10. Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis.
Chun T; Serbina NV; Nolt D; Wang B; Chiu NM; Flynn JL; Wang CR
J Exp Med; 2001 May; 193(10):1213-20. PubMed ID: 11369792
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.
Coler RN; Campos-Neto A; Ovendale P; Day FH; Fling SP; Zhu L; Serbina N; Flynn JL; Reed SG; Alderson MR
J Immunol; 2001 May; 166(10):6227-35. PubMed ID: 11342645
[TBL] [Abstract][Full Text] [Related]
12. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism.
Canaday DH; Wilkinson RJ; Li Q; Harding CV; Silver RF; Boom WH
J Immunol; 2001 Sep; 167(5):2734-42. PubMed ID: 11509617
[TBL] [Abstract][Full Text] [Related]
13. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis.
Tan JS; Canaday DH; Boom WH; Balaji KN; Schwander SK; Rich EA
J Immunol; 1997 Jul; 159(1):290-7. PubMed ID: 9200465
[TBL] [Abstract][Full Text] [Related]
14. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients.
de la Barrera S; Aleman M; Musella R; Schierloh P; Pasquinelli V; Garcia V; Abbate E; Sasiain Mdel C
Clin Exp Immunol; 2004 Oct; 138(1):128-38. PubMed ID: 15373915
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restriction.
Lewinsohn DM; Briden AL; Reed SG; Grabstein KH; Alderson MR
J Immunol; 2000 Jul; 165(2):925-30. PubMed ID: 10878367
[TBL] [Abstract][Full Text] [Related]
16. Presentation of Listeria monocytogenes antigens by major histocompatibility complex class I molecules to CD8 cytotoxic T lymphocytes independent of listeriolysin secretion and virulence.
Szalay G; Hess J; Kaufmann SH
Eur J Immunol; 1994 Jul; 24(7):1471-7. PubMed ID: 8026511
[TBL] [Abstract][Full Text] [Related]
17. MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.
Höhn H; Kortsik C; Zehbe I; Hitzler WE; Kayser K; Freitag K; Neukirch C; Andersen P; Doherty TM; Maeurer M
Scand J Immunol; 2007 May; 65(5):467-78. PubMed ID: 17444958
[TBL] [Abstract][Full Text] [Related]
18. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.
Rai PK; Chodisetti SB; Maurya SK; Nadeem S; Zeng W; Janmeja AK; Jackson DC; Agrewala JN
J Transl Med; 2018 Oct; 16(1):279. PubMed ID: 30305097
[TBL] [Abstract][Full Text] [Related]
19. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
[TBL] [Abstract][Full Text] [Related]
20. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
McMenamin C; Holt PG
J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
